Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1014P is a *pseudogene* corresponding to the U6 small nuclear RNA (snRNA) gene family[1][4]. U6 snRNA functions as an essential component of the spliceosome complex, critical for pre-mRNA splicing in eukaryotes[3][5][13]. However, pseudogenes like RNU6-1014P do **not** encode functional RNA or protein products and are usually non-coding and not transcribed, though in rare cases pseudogenes elsewhere in the genome may have regulatory or antisense RNA functions[8][10][12]. RNU6-1014P itself is classified as non-functional and has no known therapeutic, diagnostic, or biological utility, and no interaction with drugs, pathways, or diseases has been described[1][4]. **Note:** GeneCards and BioGPS, which catalog standard gene and pseudogene entries, classify RNU6-1014P solely as a pseudogene and do not attribute any protein function, associated disorders, or molecular pathways to it[1][4]. There is no evidence that this is a receptor, enzyme, transporter, or any type of classical drug target. There are no known clinical, biomarker, or safety concerns related to this pseudogene. The entry is only relevant for genomic annotation, and not as a therapeutic or drug discovery target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1014, pseudogene (RNU6-1014P).